http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe
-
Vizgen Appoints Dale Levitzke as Senior VP Global Sales and Support
-
Veracyte (VCYT) Acquires Exclusive License to NanoString (NSTG) Diagnostics Platform
-
NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference
-
NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference
-
NanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
-
NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
-
NanoString Technologies (NSTG) Falls After Lower Q3 Outlook
-
NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017
-
UPDATE – NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research
-
NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research
-
Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)
-
NanoString Technologies and MD Anderson to Collaborate on Development of Multi-Omic Assays Simultaneously Profiling Gene and Protein Expression
